Authors


Kevin B. Weiss, MD

Latest:

Board Certification: Two Perspectives

Two perspectives regarding the American Board of Psychiatry and Neurology’s (ABPN) Maintenance of Certification (MOC) program.


Kevin M. Antshel, PhD

Latest:

Developmental Disabilities From Childhood to Adulthood:

What Works for Psychiatrists in Community and Institutional Settings


Kevin M. Gray, MD

Latest:

Marijuana Use, Withdrawal, and Craving in Adolescents

Marijuana is the most commonly used illicit drug in the United States and worldwide. Initiation of use typically occurs during adolescence. The most recent epidemiological data indicate that in the United States, 42% of high school seniors have tried marijuana, 18% have used it in the past 30 days, and 5% use it daily.


Kevin M. Spencer, PhD

Latest:

Neuropsychiatric Abnormalities: A New Vista From Studies on Fundamental Properties of Neural Communication

Postmortem studies indicate that neural circuit abnormalities in schizophrenia could be reflected in gamma-band synchrony. We review findings of recent studies that demonstrate abnormal synchrony in the gamma band of the EEG in chronic schizophrenia patients, and point to links between gamma oscillations and some of the core symptoms of schizophrenia.


Kevin P. Conway, PhD

Latest:

Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders

What is comorbidity? Psychiatric comorbidity refers to the occurrence of 2 or more mental or substance use disorders within a certain period. Research shows that comorbidity of substance use and other psychiatric disorders is common and often worsens the prognosis for each disorder.


Kevin P. Hill, MD, MHS

Latest:

Cannabis Legalization: What Psychiatrists Need to Know

What's the latest update on cannabis legislation and its clinical utility?


Kevin Price, MD

Latest:

Treating Sex Offenders in a State Hospital

As a psychiatrist working in a state hospital, this author defends the long-term commitment of sexual offenders to institutions and offers insights on factors determining prognosis.


Kevin Sevarino, MD, PhD

Latest:

What All Psychiatrists Need to Know About Addictions

Because at least 10% of the US population suffers from a substance use disorder in any given year, the American Academy of Addiction Psychiatry has expanded its longstanding Board Review Course in Addictions to a more inclusive “Addictions and Their Treatment” course.


Kevin T. Kalikow, MD

Latest:

Psychiatric Medications for Children

Too often news headlines exert a major influence on our patients-and nothing in child psychiatry grabs headlines like the alleged overprescription of medicines. Physicians sidestep the debate, assuring their patients and themselves that each prescription is written only after careful consideration of risks and bene-fits.


Kevin V. Kelly, MD

Latest:

The Ethic of Humility and the Ethics of Psychiatry

A few decades ago, ethics was widely understood in the professions to be a synonym for etiquette; it described the consideration that members of a profession showed to each other. More recently, it has come to refer to the rules governing the relationship between a professional and a client or patient.


Kevin W. Olden, MD

Latest:

Functional GI Disorders: A Psychiatric Perspective

Evidence showing the effectiveness of psychopharmacologic and psychotherapeutic management of functional gastrointestinal disorders over standard medical treatment is increasing.


Khurshid A. Khurshid, MD

Latest:

A Review of Changes in DSM-5 Sleep-Wake Disorders

DSM-5 sleep-wake disorders are now more in sync with other medical disorders and sleep disorders classificatory systems. Here's what's changed.


Kim J. Masters, MD

Latest:

Portable Pulse Oximeter Use During Patient Restraint

Portable pulse oximeters are inexpensive ($150 to $600), are noninvasive, and can measure a patient's oxygen saturation in 5 to 10 seconds.


Kim Kotov, PhD

Latest:

Beyond 'Handholding': Supportive Therapy for Patients With BPD and Self-Injurious Behavior

Can supportive therapy be modified to successfully treat patients with borderline personality disorder? By using a previously developed model, NIMH-funded researchers have found supportive therapy helpful in engaging patients in treatment, developing a therapeutic alliance and achieving treatment goals. Their outcome data may provide a new treatment approach for this difficult-to-treat population.


Kim Nancy S. Duque, MD

Latest:

Fumbling Through

This is the story of Peter. I feel chosen to have gotten to know him and to have the memory of what such an experience has carved into me.


Kim T. Mueser, PhD

Latest:

Promoting Resiliency After First-Episode Psychosis

Simple but powerful strategies for drawing on patients’ existing character strengths and long-term goals.


Kimberley Kendall, MBBCh

Latest:

Intellectual Disability and Psychiatric Comorbidity: Challenges and Clinical Issues

Intellectual disability affects an individual’s functioning in everyday life. The risk for a psychiatric disorder is greater in persons with ID than in those with intelligence in the normal range. Here: the latest information on ID.


Kimberly A. Stigler, MD

Latest:

Behavioral and Pharmacologic Treatment of Aggression in Children With Autism

This article will provide an overview of treatment modalities, with emphasis on the future direction of interventions targeting aggression in children with autism.


Kimberly Martin, RN

Latest:

Benefits of Early Pharmacological Treatment in Alzheimer Disease

Successful intervention for Alzheimer disease requires an early and timely diagnosis. Caregivers of persons with AD often state that an average of 2 years passes from the onset of symptoms to a formal diagnosis.


Kimberly Young, PsyD

Latest:

Video Games: Recreation or Addiction?

Many people like to spend at least part of their free time playing video games. However, for some, what starts as innocent recreation becomes an addiction and, at times, tragedy ensues.


Kiran Rabheru, MD

Latest:

Depression in Dementia: Diagnosis and Treatment

It has been well established that there is a high incidence of depression in conjunction with Alzheimer's disease and other forms of dementia. What are the best assessment and diagnostic methods, and which treatments will produce the best results?


Kirandeep K. Somal, MD

Latest:

Referral Strategies for Patients With Co-Occurring Substance Use and Psychiatric Disorders

This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.


Kirk Heilbrun, PhD

Latest:

Forced Medication and Competency to Stand Trial: Clinical, Legal, and Ethical Issues

The authors examine legal and ethical challenges for the psychiatrist when a defendant who is incompetent to stand trial declines to take prescribed psychotropic medication.


Kirk J. Brower, MD

Latest:

The Legacy of Suicide

A personal account of a psychiatrist whose brother died by suicide.


Kiwon Lee, MD

Latest:

Edema Associated With Infarct . . . Or Something Else?

A sharp decrease in visual acuity affecting both eyes developed in a 35-year-old man 3 days after elective abdominal surgery. Six months earlier, acute B cell-type lymphoblastic leukemia was diagnosed in the patient for which he received bone marrow transplantation (BMT). Following BMT, graft-versus-host disease developed in the patient. It was treated with cyclosporine, mycophenolate mofetil (CellCept), sirolimus (Rapamune), and prednisone.


Kolleen H. Fox, PhD

Latest:

Cognitive Impairment in Patients With Bipolar Disorder

It is widely accepted that patients with schizophrenia have some degree of cognitive deficiency and that cognitive deficits are an inherent part of the disorder. Historically, there has been less focus on cognitive deficits in patients with bipolar disorder; however, numerous studies of cognition in patients with bipolar disorder, including several comprehensive meta-analyses of bipolar patients who were euthymic at the time of testing, have recently been undertaken.1-4 Each of these analyses found that cognitive impairment persists during periods of remission, mainly in domains that include attention and processing speed, memory, and executive functioning.4


Konrad Talbot, PhD

Latest:

Brain Insulin Resistance in Alzheimer Disease and Its Potential Treatment With a Mediterranean Diet and GLP-1 Analogues

This article explains the rationale and evidence for 2 novel treatments of Alzheimer disease: a reformulated Mediterranean diet and an antidiabetic agent, liraglutide, marketed as Victoza.


Kostas N. Fountoulakis, MD, PhD

Latest:

A Critical Consideration of the Most Recent Guidelines for Bipolar Depression

This article reviews the most recent (after 2010) published guidelines on bipolar depression.


Kris Bifulco, MPH

Latest:

Youth-Led Suicide Prevention in an Indigenous Rural Community

Suicide is a pervasive public health issue for adolescents in Hawaii. In response, a youth leadership model was initiated to empower young leaders in suicide prevention through evidence-based training, relationship building, and community awareness.


Kristalyn Salters-pedneault, PhD

Latest:

Strategies for Assessing and Treating Comorbid Panic and Generalized Anxiety Disorder

The 2 most common anxiety disorders are generalized anxiety disorder (GAD) and panic disorder. Approximately 5.7% of people in community samples will meet diagnostic criteria for GAD in their lifetime; the rate is about 4.7% for panic disorder (with or without agoraphobia).1 GAD-which is characterized by excessive and uncontrollable worry about a variety of topics (along with associated features such as trouble sleeping and impaired concentration)-is often chronic and is associated with significant costs to the individual and to society.

© 2025 MJH Life Sciences

All rights reserved.